9,10-dimethyl-1,2-benzanthracene has been researched along with Dwarfism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cashion, AB; Cline, JM; Ingram, RL; Ng, AH; Parlow, AF; Ramsey, MM; Sonntag, WE | 1 |
| Swanson, SM; Unterman, TG | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Dwarfism
| Article | Year |
|---|---|
Growth hormone-deficient dwarf animals are resistant to dimethylbenzanthracine (DMBA)-induced mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Dwarfism; Female; Growth Hormone; Heterozygote; Immunity, Innate; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Lew; Reference Values | 2002 |
The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Carcinogens; Cell Division; Crosses, Genetic; Disease Models, Animal; Dwarfism; Female; Growth Hormone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley | 2002 |